Skip to main content

Table 2 Intervention in both arms over time

From: Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome

 

Group A (RITUX +MMF)

Group B (Repeated RITUX only)

At randomization

First course rituximab.

Stop steroid at 14 days.

First course rituximab.

Stop steroid at 14 days.

At month 4

Add MMF and continue over study period unless any adverse event

At month 8

2nd course prophylactic rituximab if B cell normalize.

At month 16

3rd course prophylactic rituximab if B cell normalize.

At month 24

FOLLOW-UP COMPLETED

 

Any relapse during the observation period will be treated with prednisone (2 mg/kg/day) until remission, followed by 1.5 mg/kg alternate day for 1 month.

If > = 2 relapses during any 6 month period, treat by

2nd course rituximab if B cell in normal range. Continue MMF.

Add MMF.